• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间皮瘤的早期阶段、筛查与生物标志物

Early stages of mesothelioma, screening and biomarkers.

作者信息

Klebe Sonja, Henderson Douglas W

机构信息

Department of Anatomical Pathology, Flinders University of South Australia, Adelaide, SA, Australia.

出版信息

Recent Results Cancer Res. 2011;189:169-93. doi: 10.1007/978-3-642-10862-4_10.

DOI:10.1007/978-3-642-10862-4_10
PMID:21479901
Abstract

The early diagnosis of mesothelioma is notoriously difficult, both from a clinical and pathological perspective. Patients often undergo several medical investigations without definitive diagnosis. The discovery of biomarkers that can be assessed in pleural effusions, histological samples, and serum may assist with the difficult early diagnosis of mesothelioma. In this chapter we focus on those markers that have been examined in the setting of either early diagnosis of mesothelioma in symptomatic individuals or that have been proposed as suitable for screening of asbestos-exposed individuals, with an emphasis on cytology and histology.

摘要

间皮瘤的早期诊断从临床和病理角度来看都非常困难。患者通常要接受多项医学检查才能确诊。发现可在胸腔积液、组织学样本和血清中评估的生物标志物,可能有助于间皮瘤的早期诊断难题。在本章中,我们重点关注那些在有症状个体的间皮瘤早期诊断背景下进行过研究的标志物,或者那些被提议适用于筛查石棉暴露个体的标志物,重点在于细胞学和组织学方面。

相似文献

1
Early stages of mesothelioma, screening and biomarkers.间皮瘤的早期阶段、筛查与生物标志物
Recent Results Cancer Res. 2011;189:169-93. doi: 10.1007/978-3-642-10862-4_10.
2
Molecular biomarkers in malignant mesothelioma: state of the art.恶性间皮瘤中的分子生物标志物:最新进展。
Pathology. 2011 Apr;43(3):201-12. doi: 10.1097/PAT.0b013e3283445e67.
3
Current status of screening for malignant pleural mesothelioma.恶性胸膜间皮瘤筛查的现状
Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):97-104. doi: 10.1053/j.semtcvs.2009.06.007.
4
HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.高迁移率族蛋白B1及其超乙酰化异构体是检测石棉暴露和识别间皮瘤患者的敏感且特异的血清生物标志物。
Clin Cancer Res. 2016 Jun 15;22(12):3087-96. doi: 10.1158/1078-0432.CCR-15-1130. Epub 2016 Jan 5.
5
Blood tests for asbestos-related mesothelioma.用于石棉相关间皮瘤的血液检测
Oncology. 2006;71(1-2):26-31. doi: 10.1159/000100446. Epub 2007 Mar 5.
6
Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.接触天然石棉的间皮瘤和胸膜斑患者及健康受试者的血清生物标志物。
Lung. 2014 Feb;192(1):197-203. doi: 10.1007/s00408-013-9526-9. Epub 2013 Oct 30.
7
Clinical utility of diagnostic markers for malignant pleural mesothelioma.恶性胸膜间皮瘤诊断标志物的临床应用价值
Monaldi Arch Chest Dis. 2009 Mar;71(1):31-8. doi: 10.4081/monaldi.2009.374.
8
Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma.骨桥蛋白、巨核细胞增强因子和间皮素蛋白作为恶性间皮瘤患者血清标志物的比较
J Thorac Oncol. 2008 Aug;3(8):851-7. doi: 10.1097/JTO.0b013e318180477b.
9
Biomarkers for malignant pleural mesothelioma: a meta-analysis.恶性胸膜间皮瘤的生物标志物:荟萃分析。
Carcinogenesis. 2019 Nov 25;40(11):1320-1331. doi: 10.1093/carcin/bgz103.
10
[Diagnostic biomarkers of malignant pleural mesothelioma].
Med Clin (Barc). 2009 Oct 3;133(12):464-6. doi: 10.1016/j.medcli.2009.06.018. Epub 2009 Sep 13.

引用本文的文献

1
Hitting the Bull's-Eye: Mesothelin's Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma.正中靶心:间皮素作为恶性胸膜间皮瘤生物标志物和治疗靶点的作用
Cancers (Basel). 2021 Aug 4;13(16):3932. doi: 10.3390/cancers13163932.
2
Role of microRNAs in malignant mesothelioma.微小RNA在恶性间皮瘤中的作用。
Cell Mol Life Sci. 2014 Aug;71(15):2865-78. doi: 10.1007/s00018-014-1584-5. Epub 2014 Feb 23.
3
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.恶性胸膜间皮瘤诊断与治疗指南。
J Thorac Dis. 2013 Dec;5(6):E254-307. doi: 10.3978/j.issn.2072-1439.2013.11.28.
4
Parakeratotic-like cells in effusions - A clue to diagnosis of malignant mesothelioma.积液中的角化不全样细胞——恶性间皮瘤诊断的线索
Cytojournal. 2012;9:18. doi: 10.4103/1742-6413.99170. Epub 2012 Jul 28.
5
Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.肺动脉高压的今明日影像学及循环生物标志物。
Cell Mol Life Sci. 2012 Sep;69(17):2805-31. doi: 10.1007/s00018-012-0950-4. Epub 2012 Mar 25.
6
Pathological and molecular biological approaches to early mesothelioma.早期间皮瘤的病理和分子生物学方法。
Int J Clin Oncol. 2012 Feb;17(1):40-7. doi: 10.1007/s10147-011-0369-1. Epub 2012 Jan 12.
7
Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy.T0 恶性胸膜间皮瘤的诊断和治疗实用方法:全胸膜壁层切除术诊断的建议。
Int J Clin Oncol. 2012 Feb;17(1):33-9. doi: 10.1007/s10147-011-0368-2. Epub 2012 Jan 12.